Date published: 2025-11-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

Differentiated Endothelial Cell Marker Inhibitors

Differentiated endothelial cell marker inhibitors are a class of chemical compounds that specifically target molecular markers expressed on the surface of endothelial cells as they mature and differentiate. Endothelial cells, which form the inner lining of blood vessels, undergo differentiation to acquire specialized functions that regulate vascular homeostasis, permeability, and interactions with surrounding tissues. During this process, several proteins and markers become more prominent on the cell surface, serving as indicators of their differentiated state. These markers are often used in cellular studies to track the maturation and function of endothelial cells. Inhibitors targeting these markers are designed to interfere with the molecular pathways responsible for their expression or activity, thereby modulating the behavior of endothelial cells in a controlled manner.

These inhibitors can affect various cellular processes associated with endothelial differentiation, including cell adhesion, migration, and barrier function. By inhibiting specific markers, researchers can probe the molecular mechanisms that guide endothelial cell maturation and their response to environmental cues such as shear stress and growth factors. Differentiated endothelial cell marker inhibitors are valuable tools in studying angiogenesis, vascular remodeling, and the cellular interactions that underpin the formation of new blood vessels. They provide a means to disrupt or modify these processes in experimental models, offering insight into the signaling pathways that govern endothelial cell behavior. Such inhibitors allow for precise investigation of the dynamic transitions between endothelial cell states and their role in maintaining vascular integrity under physiological and experimental conditions.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Sulindac

38194-50-2sc-202823
sc-202823A
sc-202823B
1 g
5 g
10 g
$31.00
$84.00
$147.00
3
(1)

Sulindac may downregulate CD31 expression through its inhibitory action on the cyclooxygenase pathway, which could decrease the synthesis of pro-inflammatory mediators in endothelial cells.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$36.00
$68.00
$107.00
$214.00
$234.00
$862.00
$1968.00
47
(1)

Curcumin has the potential to decrease CD31 expression by suppressing the NF-κB pathway, which is known to be involved in the transcriptional activation of endothelial cell adhesion molecules.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$60.00
$185.00
$365.00
64
(2)

Resveratrol might downregulate CD31 expression by hindering the signal transduction pathways that lead to increased endothelial cell proliferation and new blood vessel formation.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$109.00
$350.00
8
(0)

Thalidomide is known to decrease neovascularization and may thus reduce CD31 expression by curtailing the pro-angiogenic growth factors in the endothelial microenvironment.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$150.00
$920.00
5
(0)

Sunitinib is a receptor tyrosine kinase inhibitor that may reduce CD31 expression by blocking the signaling cascades essential for endothelial cell survival and angiogenesis.

Aspirin

50-78-2sc-202471
sc-202471A
5 g
50 g
$20.00
$41.00
4
(1)

Aspirin might reduce CD31 expression by inhibiting thromboxane A2 synthesis, which in turn would diminish the recruitment of inflammatory cells to endothelial sites.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

Sorafenib may decrease CD31 expression by targeting RAF/MEK/ERK signaling, leading to reduced transcription of angiogenesis-related genes in endothelial cells.

Taxol

33069-62-4sc-201439D
sc-201439
sc-201439A
sc-201439E
sc-201439B
sc-201439C
1 mg
5 mg
25 mg
100 mg
250 mg
1 g
$40.00
$73.00
$217.00
$242.00
$724.00
$1196.00
39
(2)

Taxol may reduce CD31 expression by stabilizing microtubules, which leads to the arrest of endothelial cell division and migration, processes essential for angiogenesis.

Simvastatin

79902-63-9sc-200829
sc-200829A
sc-200829B
sc-200829C
50 mg
250 mg
1 g
5 g
$30.00
$87.00
$132.00
$434.00
13
(1)

Simvastatin could inhibit CD31 expression by disrupting the mevalonate pathway, which is vital for the prenylation and function of signaling proteins involved in endothelial cell activity.

Metformin

657-24-9sc-507370
10 mg
$77.00
2
(0)

Metformin has the potential to downregulate CD31 expression by activating AMPK, which negatively regulates mTOR signaling, a pathway linked to endothelial cell proliferation and angiogenesis.